Academic Validation
Erratum: Telocinobufagin inhibits the epithelial-to-mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Erratum: Telocinobufagin inhibits the epithelial-to-mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Oncol Lett. 2021 Apr;21(4):242. doi: 10.3892/ol.2021.12503.

Yuxue Gao, Lihong Shi, Zhen Cao, Xuetao Zhu, Feng Li, Ruyan Wang, Jinyuan Xu, Jinyi Zhong, Baogang Zhang, Shijun Lu

PMID: 33664806 DOI: 10.3892/ol.2021.12503

Abstract

[This corrects the article DOI: 10.3892/ol.2018.8349.].

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-N0885

Telocinobufagin

99.93%, Anticancer Agent

JAK; STAT; mTOR; PI3K; Akt; Polo-like Kinase (PLK); Na+/K+ ATPase; Apoptosis; Bacterial

Neurological Disease; Inflammation/Immunology; Infection; Cardiovascular Disease; Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2025 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us